IP Library Granted Patent US 8,247,205
Granted Patent B2
US 8,247,205 · App. 12/875,952 · Granted Aug 21, 2012

Chalcone isomerase polypeptides and crystals thereof

Assignee: The Salk Institute for Biological Studies
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,247,205
App. No.
12/875,952
Granted
Aug 21, 2012
Kind
B2
Abstract

This disclosure provides crystalline flavonoid or flavanone isomerases, isolated non-native isomerase having the structural coordinates of said crystalline isomerase, and nucleic acids encoding such non-native isomerase. Also disclosed are methods of predicting the activity and/or substrate specificity of a putative isomerase, methods of identifying potential ismerase substrates, and methods of identifying potential isomerase inhibitors.

Claims (14)

1. An isolated polypeptide comprising an amino acid sequence that has at least 85% amino acid sequence identity to the amino acid sequence set forth in SEQ ID NO:1,

wherein the isolated polypeptide has Met, Lys, Ala, His, or Gln at the position corresponding to amino acid 36 of SEQ ID NO:1, and

wherein the isolated polypeptide has chalcone isomerase enzymatic activity.

2. The isolated polypeptide of claim 1 , wherein the amino acid located at the position corresponding to amino acid 36 of SEQ ID NO:1 is Met.

3. The isolated polypeptide of claim 1 , wherein the amino acid located at the position corresponding to amino acid 36 of SEQ ID NO:1 is Ala.

4. The isolated polypeptide of claim 1 , wherein the amino acid located at the position corresponding to amino acid 36 of SEQ ID NO:1 is His.

5. The isolated polypeptide of claim 1 , wherein the amino acid located at the position corresponding to amino acid 36 of SEQ ID NO:1 is Gln.

6. The isolated polypeptide of claim 1 , wherein the amino acid located at the position corresponding to amino acid 36 of SEQ ID NO:1 is Lys.

7. The isolated polypeptide of claim 1 , wherein said polypeptide has at least 90% amino acid sequence identity to the amino acid sequence set forth in SEQ ID NO:1.

8. The isolated polypeptide of claim 1 , wherein said polypeptide has at least 95% amino acid sequence identity to the amino acid sequence set forth in SEQ ID NO:1.

9. A crystal of an unliganded chalcone isomerase polypeptide, the crystal having the space group P6 5 22 and unit cell dimensions of a=90.37 Å and c=352.86 Å,

wherein the chalcone isomerase polypeptide has the amino acid sequence set forth in SEQ ID NO:1 with R at position 36, L at position 38, T at position 48, Y at position 106, K at position 109, V at position 110, N at position 113, T at position 190, and M at position 191, respectively, of SEQ ID NO:1.

10. A crystal of a chalcone isomerase polypeptide in complex with (2S)-naringenin, the crystal having the space group P6 5 22 and unit cell dimensions of a=89.47 Å and c=351.19 Å,

wherein the chalcone isomerase polypeptide has the amino acid sequence set forth in SEQ ID NO:1 with R at position 36, L at position 38, T at position 48, Y at position 106, K at position 109, V at position 110, N at position 113, T at position 190, and M at position 191, respectively, of SEQ ID NO:1.

Assignments (1)
CONFIRMATORY LICENSE Recorded Mar 15, 2017
From: SALK INSTITUTE FOR BIOLOGICAL STUDIES
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 042014/0112 →
Continuity (3)
Division 10344051
Provisional Application 60229277 · Aug 30, 2000
Related Publication 20110020895A1 · Jan 27, 2011